214 related articles for article (PubMed ID: 26640069)
1. Fluconazole use and birth defects in the National Birth Defects Prevention Study.
Howley MM; Carter TC; Browne ML; Romitti PA; Cunniff CM; Druschel CM;
Am J Obstet Gynecol; 2016 May; 214(5):657.e1-9. PubMed ID: 26640069
[TBL] [Abstract][Full Text] [Related]
2. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study.
Zhu Y; Bateman BT; Gray KJ; Hernandez-Diaz S; Mogun H; Straub L; Huybrechts KF
BMJ; 2020 May; 369():m1494. PubMed ID: 32434758
[TBL] [Abstract][Full Text] [Related]
3. Use of oral fluconazole during pregnancy and the risk of birth defects.
Mølgaard-Nielsen D; Pasternak B; Hviid A
N Engl J Med; 2013 Aug; 369(9):830-9. PubMed ID: 23984730
[TBL] [Abstract][Full Text] [Related]
4. Associations between maternal periconceptional exposure to secondhand tobacco smoke and major birth defects.
Hoyt AT; Canfield MA; Romitti PA; Botto LD; Anderka MT; Krikov SV; Tarpey MK; Feldkamp ML
Am J Obstet Gynecol; 2016 Nov; 215(5):613.e1-613.e11. PubMed ID: 27443814
[TBL] [Abstract][Full Text] [Related]
5. Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011.
Interrante JD; Ailes EC; Lind JN; Anderka M; Feldkamp ML; Werler MM; Taylor LG; Trinidad J; Gilboa SM; Broussard CS;
Ann Epidemiol; 2017 Oct; 27(10):645-653.e2. PubMed ID: 28993061
[TBL] [Abstract][Full Text] [Related]
6. Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997-2011.
Tinker SC; Gilboa SM; Moore CA; Waller DK; Simeone RM; Kim SY; Jamieson DJ; Botto LD; Reefhuis J;
Am J Obstet Gynecol; 2020 Feb; 222(2):176.e1-176.e11. PubMed ID: 31454511
[TBL] [Abstract][Full Text] [Related]
7. Maternal butalbital use and selected defects in the national birth defects prevention study.
Browne ML; Van Zutphen AR; Botto LD; Louik C; Richardson S; Druschel CM
Headache; 2014 Jan; 54(1):54-66. PubMed ID: 24001268
[TBL] [Abstract][Full Text] [Related]
8. Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997-2011.
Papadopoulos EA; Howley MM; Fisher SC; Van Zutphen AR; Werler MM; Romitti PA; Browne ML;
Birth Defects Res; 2024 Feb; 116(2):e2308. PubMed ID: 38343154
[TBL] [Abstract][Full Text] [Related]
9. Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies.
Bérard A; Sheehy O; Zhao JP; Gorgui J; Bernatsky S; de Moura CS; Abrahamowicz M
CMAJ; 2019 Feb; 191(7):E179-E187. PubMed ID: 30782643
[TBL] [Abstract][Full Text] [Related]
10. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
[TBL] [Abstract][Full Text] [Related]
11. Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.
Polen KN; Rasmussen SA; Riehle-Colarusso T; Reefhuis J;
Birth Defects Res A Clin Mol Teratol; 2013 Jan; 97(1):28-35. PubMed ID: 23281074
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study.
Crider KS; Cleves MA; Reefhuis J; Berry RJ; Hobbs CA; Hu DJ
Arch Pediatr Adolesc Med; 2009 Nov; 163(11):978-85. PubMed ID: 19884587
[TBL] [Abstract][Full Text] [Related]
13. Antifungal drugs and the risk of selected birth defects.
Carter TC; Druschel CM; Romitti PA; Bell EM; Werler MM; Mitchell AA;
Am J Obstet Gynecol; 2008 Feb; 198(2):191.e1-7. PubMed ID: 18226621
[TBL] [Abstract][Full Text] [Related]
14. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011.
Tinker SC; Reefhuis J; Bitsko RH; Gilboa SM; Mitchell AA; Tran EL; Werler MM; Broussard CS;
Birth Defects Res; 2019 Jun; 111(10):613-620. PubMed ID: 30891943
[TBL] [Abstract][Full Text] [Related]
15. Risk of malformations and other outcomes in children exposed to fluconazole in utero.
Sorensen HT; Nielsen GL; Olesen C; Larsen H; Steffensen FH; Schønheyder HC; Olsen J; Czeizel AE
Br J Clin Pharmacol; 1999 Aug; 48(2):234-8. PubMed ID: 10417502
[TBL] [Abstract][Full Text] [Related]
16. Exposure to fluconazole and risk of congenital malformations in the offspring: A systematic review and meta-analysis.
Alsaad AM; Kaplan YC; Koren G
Reprod Toxicol; 2015 Apr; 52():78-82. PubMed ID: 25724389
[TBL] [Abstract][Full Text] [Related]
17. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth.
Mølgaard-Nielsen D; Svanström H; Melbye M; Hviid A; Pasternak B
JAMA; 2016 Jan; 315(1):58-67. PubMed ID: 26746458
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Medication Use and Birth Defects in the National Birth Defects Prevention Study.
Howley MM; Fisher SC; Van Zutphen AR; Waller DK; Carmichael SL; Browne ML;
Birth Defects Res; 2017 Nov; 109(18):1471-1481. PubMed ID: 28758357
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotic use during pregnancy and birth defect risk: National Birth Defects Prevention Study, 1997-2011.
Anderson KN; Ailes EC; Lind JN; Broussard CS; Bitsko RH; Friedman JM; Bobo WV; Reefhuis J; Tinker SC;
Schizophr Res; 2020 Jan; 215():81-88. PubMed ID: 31761471
[TBL] [Abstract][Full Text] [Related]
20. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.
Anderka M; Mitchell AA; Louik C; Werler MM; Hernández-Diaz S; Rasmussen SA;
Birth Defects Res A Clin Mol Teratol; 2012 Jan; 94(1):22-30. PubMed ID: 22102545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
